This inventor holds 8 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Kaneq Pharma Inc., Merck + Co., Inc., Merck Frosst Canada, Inc.. Active years: 2006-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Montreal, CA (2006)
- Carlsbad Springs, CA (2006 - 2007)
- Carlsband Springs, CA (2011)
- Russell, CA (2012 - 2016)
Company Filing History:
4 out of 4 
2 out of 4,770 
2 out of 212 
Years Active: 2006-2016
Title: Marie-Claire Wilson: Innovator in Pharmaceutical Chemistry
Introduction
Marie-Claire Wilson is a prominent inventor based in Russell, Canada, known for her significant contributions to pharmaceutical chemistry. With a total of eight patents to her name, she has made remarkable strides in the field of enzyme inhibitors, particularly focusing on PTP-1B, which plays a crucial role in various diseases, including diabetes.
Latest Patents
Among her latest innovations are the Fused Aromatic PTP-1B Inhibitors. This invention encompasses a novel class of compounds that serve as inhibitors of the PTP-1B enzyme. The pharmaceutical compositions developed from these compounds are aimed at treating or preventing PTP-1B mediated diseases, including diabetes. The potential impact of her work is significant, as it addresses critical health issues affecting millions worldwide.
Career Highlights
Marie-Claire has worked with notable companies in the pharmaceutical industry, including Kaneq Pharma Inc. and Merck & Company, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research and development in drug formulation and enzyme inhibition.
Collaborations
Some of her notable coworkers include Yongxin Han and John Colucci, who have collaborated with her on various projects, enhancing the scope and impact of her research.
Conclusion
Marie-Claire Wilson's innovative work in developing PTP-1B inhibitors showcases her dedication to advancing pharmaceutical science. Her contributions are paving the way for new treatments that could significantly improve the lives of those affected by diabetes and other related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile